NCT02228655View on ClinicalTrials.gov

An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

July 31, 2015

Conditions
Anemia in Chronic Kidney Disease
Interventions
DRUG

FMX-8

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
lead

FerruMax Pharmaceuticals, Inc.

INDUSTRY